Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 83008-009

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 83008-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quality Care Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (1)

Label for Tramadol HCl ER Tablets USP 200 mg extended-release tablets, 30 count, packaged and distributed by Quality Care Products, LLC. The label includes a warning about habit-forming potential, storage instructions at 77 degrees F, and notes the product is Rx only. Manufacturer is Lupin Limited, India, for Lupin Pharmaceuticals, Inc. NDC 83008-009-30 visible.*

FDA Label Image

Image-1 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 01)

Chemical structure of Tramadol Hydrochloride showing its molecular arrangement including phenyl, cyclohexanol, and dimethylaminomethyl groups along with the hydrochloride salt.*

FDA Label Image

Image-2 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 02)

A line graph comparing tramadol concentration (ng/mL) over time (hours) for two formulations: Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol Hydrochloride Tablets 50 mg every 6 hours. The graph shows fluctuations in concentration levels for both dosing regimens across a 24-hour period.*

FDA Label Image

Image-3 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 03)

A line graph comparing M1 concentration (ng/mL) over 24 hours for Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily versus Tramadol Hydrochloride Tablets 50 mg every 6 hours. The x-axis shows time in hours, and the y-axis shows M1 concentration. Two lines represent concentration profiles for each dosage form over time.*

FDA Label Image

Image-4 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 04)

A line chart titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' showing the percent of patients achieving various levels of response threshold, defined as percent improvement from baseline. The chart compares response rates for Tramadol Hydrochloride Extended-Release Tablets at doses of 100 mg, 200 mg, 300 mg, and 400 mg versus placebo.*

FDA Label Image

Image-5 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 05)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 015 Arthritis Pain Intensity VAS Responder Analysis Patients Achieving Various Levels of Response Threshold.' It compares the percent of patients achieving response between Tramadol Hydrochloride extended-release tablets and placebo. The x-axis represents response threshold as percent improvement from baseline, from 0 to 100%, and the y-axis represents percent of patients achieving response, from 0 to 60%. Two lines depict patient response rates: one with circles for the Tramadol Hydrochloride group, consistently higher, and one with stars for placebo, lower across thresholds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.